Skip to main content
. 2023 Jan 28;14:462. doi: 10.1038/s41467-023-36222-8

Fig. 1. Laboratory surveillance of Shigella sonnei infections in France, 2005–2021.

Fig. 1

The upper panel shows the number of isolates, by patient sex, received and analyzed per year. The middle panel shows the percentage of isolates displaying phenotypic resistance to ciprofloxacin (CIP), azithromycin (AZM), or third-generation cephalosporins (3GCs). The lower panel shows the number of extensively drug-resistant (XDR) S. sonnei isolates detected per year. XDR means combined resistance to CIP, AZM, and 3GCs.